Biotech Nutraceuticals
Being a multi-faceted, vision driven organization, Genom Biotech has paved its path into the biotechnology research and development. Biotechnology is a lucrative market with tremendous growth potential. Since the last decade, biotech products have started entering in the market and today they account for the 50% of the new drug developments. Genom is strategically aligning its resources to support biotech research and formulation development. Our endeavor will ensure our product meet regulatory approvals and benefit the mankind.
-
Our core competencies include
-
Product research and development
-
Regulatory approvals and commercialization
-
Intellectual property protection
-
Formulation optimization for protein, enzyme and probiotic products
Research based new product development
NUTRACEUTICALS:
Even in the time of economic down-turn; the global nutraceutical market has successfully posted healthy growth figures. Increasing elderly population, changing lifestyle, higher spending capacity and building health awareness have been the key drivers. The nutraceutical market was worth US $123bn in 2008 and is expected to grow to US $176bn by 2013.
Realizing the importance and indispensability of nutraceuticals across disease segments, Genom has forayed into nutraceutical business with its quality products like diaterary fibers and enzymes, immunity boosters and food supplements. Genom Biotech will continue to leverage on emerging opportunities in biotechnology and nutraceuticals to ensure a remarkable future with consistent growth and supply of high value products to mankind. Research Collaborations:
Genom biotech has collaborated with Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology (IIT), Delhi for new drug development of biological origin.
Our product pipeline
-
Development of Probiotic supplement
-
Development of Enzyme supplement
-
Development of Protein and Amino acid s supplement
-
Development of natural plant products